201 related articles for article (PubMed ID: 27061865)
1. Multiple parapelvic cysts in Fabry disease.
Azancot MA; Vila J; Domínguez C; Serres X; Espinel E
Nefrologia; 2016; 36(3):310-2. PubMed ID: 27061865
[TBL] [Abstract][Full Text] [Related]
2. De novo mutation in a male patient with Fabry disease: a case report.
Iemolo F; Pizzo F; Albeggiani G; Zizzo C; Colomba P; Scalia S; Bartolotta C; Duro G
BMC Res Notes; 2014 Jan; 7():11. PubMed ID: 24398019
[TBL] [Abstract][Full Text] [Related]
3. Fabry disease. A case report.
Kotnik J; Kotnik F; Desnick RJ
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):15-9. PubMed ID: 15818441
[TBL] [Abstract][Full Text] [Related]
4. Fabry disease in patients with end-stage renal failure: the potential benefits of screening.
Bekri S; Enica A; Ghafari T; Plaza G; Champenois I; Choukroun G; Unwin R; Jaeger P
Nephron Clin Pract; 2005; 101(1):c33-8. PubMed ID: 15886492
[TBL] [Abstract][Full Text] [Related]
5. Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes.
Glass RB; Astrin KH; Norton KI; Parsons R; Eng CM; Banikazemi M; Desnick RJ
J Comput Assist Tomogr; 2004; 28(2):158-68. PubMed ID: 15091117
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel mutation and prevalence study for fabry disease in Japanese dialysis patients.
Nishino T; Obata Y; Furusu A; Hirose M; Shinzato K; Hattori K; Nakamura K; Matsumoto T; Endo F; Kohno S
Ren Fail; 2012; 34(5):566-70. PubMed ID: 22563919
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.
San Román-Monserrat I; Moreno-Flores V; López-Cuenca D; Rodríguez-González-Herrero E; Guillén-Navarro E; Rodríguez-González-Herrero B; Alegría-Fernández M; Poza-Cisneros G; Piñero-Fernández JA; Sornichero-Martínez J; Gimeno-Blanes JR
Med Clin (Barc); 2014 Jun; 142(11):497-504. PubMed ID: 24679964
[TBL] [Abstract][Full Text] [Related]
8. Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure.
Van Loo A; Vanholder R; Madsen K; Praet M; Kint J; De Paepe A; Messiaen L; Lameire N; Hasholt L; Sørensen SA; Ringoir S
Am J Nephrol; 1996; 16(4):352-7. PubMed ID: 8739292
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease presenting as apical left ventricular hypertrophy in a patient carrying the missense mutation R118C.
Caetano F; Botelho A; Mota P; Silva J; Leitão Marques A
Rev Port Cardiol; 2014 Mar; 33(3):183.e1-5. PubMed ID: 24661928
[TBL] [Abstract][Full Text] [Related]
10. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
11. A novel small insertion mutation, C.1030_1031ins (T) in α-galactosidase A leads to renal variant fabry disease.
Choi JS; Kim CS; Park JW; Bae EH; Ma SK; Choi YD; Kim GH; Yoo HW; Kim SW
Ren Fail; 2012; 34(3):390-3. PubMed ID: 22260214
[TBL] [Abstract][Full Text] [Related]
12. Novel α-Galactosidase A Mutation (K391E) in a Young Woman With Severe Cardiac and Renal Manifestations of Fabry Disease.
Wakakuri H; Nakamura S; Utsumi K; Shimizu W; Yasutake M
Int Heart J; 2016 Sep; 57(5):637-9. PubMed ID: 27593536
[TBL] [Abstract][Full Text] [Related]
13. Parapelvic cysts, a distinguishing feature of renal Fabry disease.
Pisani A; Petruzzelli Annicchiarico L; Pellegrino A; Bruzzese D; Feriozzi S; Imbriaco M; Tedeschi E; Cocozza S; De Rosa D; Mignani R; Veroux M; Battaglia Y; Concolino D; Sestito S; Pieruzzi F; Caroti L; Manna R; Zizzo C; Santangelo M; Sabbatini M; Riccio E
Nephrol Dial Transplant; 2018 Feb; 33(2):318-323. PubMed ID: 28371803
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report.
Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S
BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503
[TBL] [Abstract][Full Text] [Related]
15. Early renal failure in childhood in a male with Fabry disease.
Hogh JN; Ebrahim H; Moochhala S; Ramaswami U
BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35537774
[TBL] [Abstract][Full Text] [Related]
16. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches.
Germain DP; Poenaru L
Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848
[TBL] [Abstract][Full Text] [Related]
17. Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area.
Zizzo C; Testa A; Colomba P; Postorino M; Natale G; Pini A; Francofonte D; Cammarata G; Scalia S; Sciarrino S; Zoccali C; Duro G
Kidney Blood Press Res; 2018; 43(4):1344-1351. PubMed ID: 30099469
[TBL] [Abstract][Full Text] [Related]
18. No accumulation of globotriaosylceramide in the heart of a patient with the E66Q mutation in the α-galactosidase A gene.
Kobayashi M; Ohashi T; Fukuda T; Yanagisawa T; Inomata T; Nagaoka T; Kitagawa T; Eto Y; Ida H; Kusano E
Mol Genet Metab; 2012 Dec; 107(4):711-5. PubMed ID: 23146289
[TBL] [Abstract][Full Text] [Related]
19. [A boy with Fabry disease with the onset at the age of four].
Liu YP; Huang Y; Wang Q; Wu TF; Ma YY; Li XY; Song JQ; Yang YL
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):307-11. PubMed ID: 23591357
[TBL] [Abstract][Full Text] [Related]
20. The 30-year Natural History of Non-classic Fabry Disease with an R112H Mutation.
Muto R; Inagaki K; Kato N; Maruyama S; Akahori T
Intern Med; 2022 Jun; 61(11):1727-1730. PubMed ID: 34803097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
